One Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.64M | Hold |
12,155
| – | – | 0.07% | 182 |
|
|
2026
Q1 | $2.64M | Buy |
12,155
+1,603
| +15% | +$356K | 0.07% | 182 |
|
|
2025
Q4 | $2.41M | Buy |
10,552
+1,646
| +18% | +$375K | 0.07% | 167 |
|
|
2025
Q3 | $2.06M | Sell |
8,906
-65
| -0.7% | -$13.2K | 0.07% | 158 |
|
|
2025
Q2 | $1.67M | Sell |
8,971
-170
| -2% | -$31.6K | 0.06% | 172 |
|
|
2025
Q1 | $1.92M | Sell |
9,141
-656
| -7% | -$128K | 0.06% | 168 |
|
|
2024
Q4 | $1.74M | Sell |
9,797
-1,928
| -16% | -$354K | 0.06% | 169 |
|
|
2024
Q3 | $2.32M | Sell |
11,725
-251
| -2% | -$46.8K | 0.07% | 161 |
|
|
2024
Q2 | $2.05M | Buy |
11,976
+4,533
| +61% | +$751K | 0.07% | 165 |
|
|
2024
Q1 | $1.36M | Buy |
7,443
+325
| +5% | +$56K | 0.05% | 166 |
|
|
2023
Q4 | $1.1M | Buy |
7,118
+89
| +1% | +$13K | 0.04% | 173 |
|
|
2023
Q3 | $1.05M | Sell |
7,029
-202
| -3% | -$29.7K | 0.05% | 163 |
|
|
2023
Q2 | $974K | Sell |
7,231
-68
| -0.9% | -$9.97K | 0.04% | 173 |
|
|
2023
Q1 | $1.16M | Sell |
7,299
-840
| -10% | -$128K | 0.06% | 167 |
|
|
2022
Q4 | $1.32M | Sell |
8,139
-149
| -2% | -$22.8K | 0.07% | 158 |
|
|
2022
Q3 | $1.11M | Buy |
8,288
+49
| +0.6% | +$7.03K | 0.07% | 161 |
|
|
2022
Q2 | $1.26M | Buy |
8,239
+907
| +12% | +$139K | 0.07% | 159 |
|
|
2022
Q1 | $1.19M | Sell |
7,332
-20
| -0.3% | -$2.9K | 0.06% | 164 |
|
|
2021
Q4 | $995K | Buy |
7,352
+3,983
| +118% | +$470K | 0.08% | 136 |
|
|
2021
Q3 | $363K | Sell |
3,369
-377
| -10% | -$43.1K | 0.03% | 171 |
|
|
2021
Q2 | $421K | Buy |
3,746
+293
| +8% | +$33K | 0.04% | 166 |
|
|
2021
Q1 | $373K | Buy |
3,453
+95
| +3% | +$10.2K | 0.04% | 141 |
|
|
2020
Q4 | $360K | Buy |
+3,358
| New | +$323K | 0.04% | 144 |
|
|
2020
Q3 | – | Sell |
-4,200
| Closed | -$412K | – | 158 |
|
|
2020
Q2 | $412K | Sell |
4,200
-1,295
| -24% | -$114K | 0.06% | 134 |
|
|
2020
Q1 | $419K | Buy |
+5,495
| New | +$468K | 0.07% | 136 |
|
|
2017
Q1 | – | Sell |
-3,207
| Closed | -$201K | – | 127 |
|
|
2016
Q4 | $201K | Hold |
3,207
| – | – | 0.06% | 123 |
|
|
2016
Q3 | $202K | Buy |
+3,207
| New | +$208K | 0.07% | 119 |
|
|
2014
Q4 | – | Sell |
-2,421
| Closed | -$140K | – | 144 |
|
|
2014
Q3 | $140K | Buy |
+2,421
| New | +$134K | 0.05% | 156 |
|
Other funds holding ABBV
One Capital Management's ABBV Position: Q2 2026 in Review
One Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 12,155 shares worth $2.64M. The position accounts for 0.07% of the portfolio, ranked #182.
One Capital Management first reported a position in ABBV in Q3 2014 and has held it in 28 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- One Capital Management held 12,155 shares of AbbVie worth $2.64M as of Q2 2026.
- One Capital Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.07% of One Capital Management's portfolio in Q2 2026, its #182 holding.
- One Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 28 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.